![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JL Ellis, BJ Undem, JS Kays, SV Ghanekar, HG Barthlow and CK Buckner
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland.
The abilities of agonists selective for neurokinin (NK)-1 (Ac- [Arg6,Sar9,Met(O2)11]-SP6-11, ASMSP), NK-2 ([beta-Ala8]-NKA4-10) and NK- 3 ([Asp5,6,MePhe8]-SP5-11, senktide analog) receptors to contract human bronchus and guinea pig and hamster trachea were studied. The antagonism of these responses by selective antagonists was also examined. In the human bronchus and hamster trachea, [beta-Ala8]-NKA4- 10 was the most potent agonist, whereas ASMSP and senktide analog failed to elicit contractions greater than 50% of the maximum response even at concentrations reaching 1 to 3 x 10(-4) M. By contrast, both ASMSP and [beta-Ala8]-NKA4-10 were potent contractile agonists in guinea pig trachea. In all tissues, the selective NK-1 receptor antagonist (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)-methyl]- 1-a zab icyclo- [2.2.2]octan-3-amine (CP 96,345) was without effect on contractile responses to [beta-Ala8]-NKA4-10. Blockade by CP 96,345 of responses to ASMSP was, however, observed in the guinea pig trachea, but not in human bronchus or hamster trachea. Responses to ASMSP in human bronchus and hamster trachea were inhibited by NK-2 antagonists, whereas these compounds had little effect on responses to ASMSP in guinea pig trachea. In all tissue types, responses to senktide analog were inhibited by NK-2 antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  K. Mizuta, G. Gallos, D. Zhu, F. Mizuta, F. Goubaeva, D. Xu, R. A. Panettieri Jr., J. Yang, and C. W. Emala Sr. Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L523 - L534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.F. Joos and B. O'Connor Indirect airway challenges Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Freed, S. McCulloch, T. Meyers, and R. Suzuki Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Canning, S. M. Reynolds, L. U. Anukwu, R. Kajekar, and A. C. Myers Endogenous neurokinins facilitate synaptic transmission in guinea pig airway parasympathetic ganglia Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R320 - R330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Rumsey, D. Aharony, R. A. Bialecki, B. M. Abbott, H. G. Barthlow, R. Caccese, S. Ghanekar, D. Lengel, M. McCarthy, B. Wenrich, et al. Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 307 - 315. [Abstract] [Full Text]
|
|
|
|
|
|
S. DAOUI, C. COGNON, E. NALINE, X. EMONDS-ALT, and C. ADVENIER Involvement of Tachykinin NK3 Receptors in Citric Acid-induced Cough and Bronchial Responses in Guinea Pigs Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sherwood, P. J. Mauser, and R. W. Chapman Bronchoconstrictor and Respiratory Effects of Neurokinin A in Dogs J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 788 - 793. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
